Clinical Research

Video of Gregg Stone, MD, explaining the late-breaking RELIEVE-HF trial he presented at ACC.24 this week. #ACC24 #ACC2024

Inter-atrial shunt in RELIEVE-HF improves symptoms in HFrEF, but not HFpEF

Gregg Stone, MD, explains the details of the late-breaking RELIEVE-HF trial at ACC.24, where an inter-atrial shunt improved symptoms in HFrEF, but not in HFpEF patients.

artificial intelligence in healthcare

AI able to assess invasiveness of lung lesions to aid in surgery

In a study, the most accurate model combined deep-learning with a radionomics approach.

Video of Howard Herrmann, MD, explaining the details of the SMART trial that looked at TAVR in small annulus and found self-expanding TAVR valves work better in these patients than balloon-expanding TAVR.

Cardiologist highlights key takeaways from SMART trial, which looked at TAVR in small annulus patients

Howard C. Herrmann, MD, principal investigator of the SMART trial, discussed his team's research on self-expanding vs. balloon-expandable TAVR valves in patients with small annuli. 

Thumbnail

Ultrasound-damaged organoids show how brain injury may progress into ALS

Seeking ways to protect the brain, the researchers found a gene called KNNJ2 that aids in muscle contraction and relaxation.

Thumbnail

Ultrasound specialists update recommendations for endometriosis screening

The authors recommend tweaking pelvic ultrasound with new maneuvers that produce clearer images.

ACC.24, the annual meeting of the American College of Cardiology (ACC), kicked off on Saturday, April 6, with a series of late-breaking clinical trials focused on testing the safety and effectiveness of new treatment strategies.

Day 1 at ACC.24: Late-breakers examine potential new heart attack, heart failure treatments

ACC.24 in Atlanta began Saturday, April 6, with a series of late-breaking clinical trials exploring brand new treatment strategies. 

Thickening of artery wall, reduced heart function linked to HIV

HIV carries a fourfold increase in risk of sudden cardiac death, even in asymptomatic patients.

Thumbnail

Microwave ablation an effective, safer treatment for thyroid carcinoma, study finds

A comparative analysis against surgical resection found MWS had the same survival rate and caused fewer side effects.